A gene therapy has been used for the first time to treat Huntington's disease, with reports indicating it may slow the disease's progression. The treatment has shown promise in a trial, although regulatory hurdles may still need to be overcome. The development is being seen as a significant breakthrough and a potential turning point in the research into the disease.